FDA: Byetta drug label is revised
Monday, November 2, 2009 - 16:21
in Health & Medicine
WASHINGTON, Nov. 2 (UPI) -- The U.S. Food and Drug Administration says it has approved a Byetta drug label revision to include information about possible kidney function problems.
Read the whole article on UPI
More from UPI
Related
- Off-label use: Oft not evidence basedFri, 21 Aug 2009, 5:56:39 EDT
- Stanford researchers call for drug labels to disclose lack of comparison with existing medicationsWed, 12 Aug 2009, 18:29:24 EDT
- ICT fails to accelerate drug approvalsThu, 19 Nov 2009, 9:58:09 EST
- 14 drugs identified as most urgently needing study for off-label use, Stanford professor saysMon, 24 Nov 2008, 13:22:08 EST
- Off-label morning sickness drug deemed safe for fetuses -- Ben-Gurion U. researchersWed, 10 Jun 2009, 17:30:25 EDT